期刊文献+

250株鲍曼不动杆菌对14种抗菌药物的药敏测定 被引量:3

Susceptibility test of 250 acinetobacter baumannii strains to 14 antimicrobial agents
下载PDF
导出
摘要 目的对2005年1月至2007年3月,本院分离的鲍曼不动杆菌耐药状况进行分析。方法收集临床分离的鲍曼不动杆菌,培养鉴定。采用纸片扩散法(K-B法),根据美国临床实验室标准化委员会(NCCLS)相关文件判断结果。结果期间分离出250株鲍曼不动杆菌,对14种抗菌药物体外敏感试验结果显示,对氨曲南耐药率为88%、头孢哌酮72%、复方磺胺甲口恶唑56.4%、替卡西林/克拉维酸55.6%、哌拉西林53.2%、庆大霉素51.2%、头孢吡肟50.4%、左氧氟沙星48.8%、头孢他啶48.4%、哌拉西林/他唑巴坦46.8%、妥布霉素44.8%、阿米卡星42%、头孢哌铜/舒巴坦14%、亚胺培南13.6%。结论鲍曼不动杆菌对14种抗菌药物均有不同程度的耐药。 AIM To analyze the antimicrobial resistance of acinetobacter baumannii isolates in our hospital from January ,2005 to March, 2007. METHODS Acinetobacter baumannii isolates were collected. These tested by K - B methods and judged to NCCLS. RESULTS A total of 250 acinetobacter baumannii isolates were isolated. The results of susceptibility test to 14 kinds of antibioties showed the resistance rates were aztreonam 88%, cefoperazone 72%, SMZ 56.4%, ticarcillin/clavulanic acid 55.6%, piperacillin 53.2%, gentamicin chains 51.2%, cefepime 50.4%, levofloxacin 48.8%, ceftazidime for injection 48.4%, tazocin 46.8%, tobramycin 44.8%, amikacin 42%, cefoperazone/ sulbactam 14% ,imipenem 13.6%. CONCLUSION Acinetobacter baumarmii all show some resistance to 14 kind of antibiltics.
出处 《中国临床药学杂志》 CAS 2008年第2期112-113,共2页 Chinese Journal of Clinical Pharmacy
关键词 鲍曼不动杆菌 标本种类 耐药率 acinetobacter baumannii kind of sample resistance rate
  • 相关文献

参考文献3

二级参考文献18

  • 1孙景勇,倪语星.CTX-M-3超广谱-和TEM-1广谱β-内酰胺酶基因同时存在于大肠埃希菌[J].中华微生物学和免疫学杂志,2001,21(S1):79-81. 被引量:14
  • 2Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment [J].Clin Microbiol Infect, 2002,8 (11): 687. 被引量:1
  • 3Mahgoub S, Ahmed J, Glatt AE. Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii[J]. Am J Infect Control,2002,30(7) :386. 被引量:1
  • 4Wood GC,Hanes SD,Croce MA,et al.Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia[J].Clin Infect Dis,2002,34:1425-1430. 被引量:1
  • 5Jellison TK,Mckinnon PS,Rybak MJ.Epidemiology,resistance,and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam[J].Pharmacotherapy,2001,21:142-148. 被引量:1
  • 6Cisneros JM,Reyes MJ,Pachon J,et al.Bacteremia due to Acinetobacter baumannii:epidemiology,clinical findings,and prognostic features[J].Clin Infect Dis 1996,22:1026-1032. 被引量:1
  • 7Mandell GL,Bennett JE,Dolin R.Mandell,Douglas,and Bennett's Principles and Practice of Infectious Diseases[M].5th Edition,Pennsylvania:Churchill Livingstone,2000,2339-2344. 被引量:1
  • 8Hancock RE. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria[J]. Clin Infect Dis, 1998, 27(suppl 1):s93-99 被引量:1
  • 9Bonnet R, Sampaio JL, Labia R, et al. A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil[J]. Antimicrob Agents Chemother, 2000,44: 1936-1942 被引量:1
  • 10Medeiros AA. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics[J]. Clin Infect Dis, 1997, 4(suppl 1):s19-S45 被引量:1

共引文献72

同被引文献20

  • 1张翊,卢建平.鲍氏不动杆菌感染及耐药性变化的趋势[J].中华医院感染学杂志,2004,14(3):341-343. 被引量:91
  • 2田维珍,邓光荣,陈芳.不动杆菌的耐药酶检测[J].临床检验杂志,2005,23(2):131-132. 被引量:14
  • 3王辉,孙宏莉,宁永忠,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.不动杆菌属多重耐药及泛耐药的分子机制研究[J].中华医学杂志,2006,86(1):17-22. 被引量:183
  • 4Naas T, Levy M, Hirschauer C, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia [J]. J Clin Microbiol, 2005, 43(9): 4826-4829. 被引量:1
  • 5Chu Y W, Afzal-Shah M, Houang E T, et al. IMP-4, a novel metallo-β -lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998[J]. Antimicrob Agents Chemother, 2001, 45(3): 710. 被引量:1
  • 6Quale J, Bratu S, Landman D, et al. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City [J]. Clin Infect Dis, 2003, 37(2): 214-220. 被引量:1
  • 7Magnet S, Courvalin P, Lambert T. Resistance- Nodulation-Cell Division-type effiux pump involved in aminoglycoside resistance in Acinetobaeter baumannii strain BM4454[J]. Antimicrob Agents Chemother, 2001, 45(12):3375-3380. 被引量:1
  • 8Lin L, Ling B D, Li X Z. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobaeter caleoaceticus complex[J], Int J Antimierob Agents, 2009,33(1):27-32. 被引量:1
  • 9Rello J. Acinetobacter baumannii infections in the ICU: customization is the key[J].Chest, 1999, 115:1226. 被引量:1
  • 10Damier-Piolle L, Magnet S, Bremont S, et al. AdeIJK, a RND pump effluxing multiple antibiotics in Acinetobacter baumannii[J].Antimierob Agents Chemother, 2008, 52(2): 557-562. 被引量:1

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部